KYAN’s mission is to unlock the full potential of combination therapies, addressing unmet needs where monotherapies and single target development efforts fail.

RATIONAL
From years of research and validation, we have crafted a streamlined approach to find safe and effective combinations from endless possibilities.

Our patented computational methodology works to overcome low success rates and the soaring costs of combination development based on serendipity, convenience, and incomplete knowledge.

RELEVANT
We use data from efficiently designed experiments. For each case, we ask the question: What is the best combination? We obtain a faster, more accurate answer by looking at prospective data rather than sifting through mounds of information that already exists and is mostly irrelevant.

REAL
We validate our results against disease models from in vitro to human. Our platform has been used for successful interventional combination treatment for real-life patients.